Journey Medical (DERM) Free Cash Flow (2020 - 2026)
Journey Medical's (DERM) quarterly Free Cash Flow came in at $2.9 million in Q1 2026, up 202.72% YoY from $960957.4 in Q1 2025, and up 146.29% on a QoQ basis from -$6.3 million in Q4 2025.
Journey Medical (DERM) Free Cash Flow (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Free Cash Flow data on file, last reported at $2.9 million in Q1 2026.
- Quarterly Free Cash Flow rose 202.72% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.7 million (up 3.46% YoY) and the FY2025 annual result came in at -$12.4 million, up 48.44% from the prior year.
- Free Cash Flow rose to $2.9 million in Q1 2026, from -$6.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $18.7 million in Q3 2023 to a low of -$19.1 million in Q1 2022.
- A 5-year average of -$3.1 million and a median of -$3.3 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1504.56% — and 2023, when it soared 357.44%.
- Tracing DERM's Free Cash Flow over 5 years: stood at -$3.8 million in 2022, then slumped by 330.66% to -$16.5 million in 2023, then soared by 113.47% to $2.2 million in 2024, then slumped by 382.43% to -$6.3 million in 2025, then surged by 146.29% to $2.9 million in 2026.
- The last three Free Cash Flow figures came in at $2.9 million (Q1 2026), -$6.3 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -942,000.00 |
| Jun 30, 2025 | -942,000.00 |
| Mar 31, 2025 | -2.83 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Mar 31, 2024 | -5.02 Mn |